Nyxoah (CHIX:NYXHB) Short Interest


CHIX:NYXHB Nyxoah SA CHIX:NYXHB
53 GF Score
Price €25.40
GF Value €437.15
! 5 Warning Signs
View Full Analysis

What is Nyxoah Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:NYXHB vs ISRG, BDX, MDLN: Short Interest Comparison

For the Medical Instruments & Supplies subindustry, Nyxoah's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyxoah Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Short Interest distribution charts can be found below:

* The bar in red indicates where Nyxoah's Short Interest falls into.


CHIX:NYXHB
53GF Score
Nyxoah SA CHIX:NYXHB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nyxoah (CHIX:NYXHB) Overvalued in 2026?

Based on GuruFocus' analysis, Nyxoah stock appears to be undervalued. The current stock price of €25.40 is trading 94.2% below its estimated GF Value™ of €437.15.

Key valuation signals for CHIX:NYXHB:

  • Short Interest:
  • GF Value™: €437.15 vs. price of €25.40 (94.2% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the CHIX:NYXHB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nyxoah Business Description

Address Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
53GF Score

Get the complete analysis for CHIX:NYXHB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.40
Price
€437.15
GF Value